Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1999 Feb;90(2):136–143. doi: 10.1111/j.1349-7006.1999.tb00726.x

Tea Polyphenol Intake and Changes in Serum Pepsinogen Levels

Nobuyuki Hamajima 1,✉, Kazuo Tajima 1,✉, Suketami Tominaga 2,✉, Akira Matsuura 3,✉, Masayoshi Kuwabara 4,✉, Katashi Okuma 5,✉
PMCID: PMC5926041  PMID: 10189883

Abstract

Following a phase I study, a phase II study was conducted to evaluate the effects of two different doses of tea polyphenols on serum pepsinogen levels. Subjects were patients aged 40 to 69 years who had undergone gastroscopy between 1995 and 1997 at Aichi Cancer Center Hospital, and had been found to have no disease requiring medication. Those with pepsinogen I <70 ng/ml and pepsinogen I/II ratio ?6 were included in this study. Capsules containing 100 mg of tea polyphenols were administered for 1 year: 1 capsule per day for 101 patients (42 males and 59 females), and 6 capsules (equivalent to 10 cups) per day for 83 patients (30 males and 53 females). The enrollment of the 1 capsule group preceded that of the 6 capsule group, in which re‐participation was allowed. Blood samples were obtained 1 year after participation from 86 participants of the 1 capsule group and 77 participants (43 new participants and 34 re‐participants) of the 6 capsule group. The compliance in polyphenol capsule intake ranged from 11.4 to 105.7% (87.6% on average) of the scheduled amount for the 1 capsule group and 3.2 to 112.3% (77.8% on average) for the 6 capsule group. No serious polyphenol‐related adverse effects were reported. The difference in pepsinogen I between before and after 1 year intake of the polyphenol was 3.1 ng/ml for the 43 participants of the 6 capsule group, but 3.5 ng/ml for the 1 capsule group. The mean pepsinogen I/II ratio for the 43 participants increased from 2.37 by 0.08. This increase was not larger than that for the 1 capsule group (from 2.61 by 0.11). Among 34 participants in both interventions, no significant increase in pepsinogen I and I/II ratio for the 6 capsule intervention was observed. This result suggests that additional polyphenol intake for 1 year in Japanese does not improve pepsinogen levels, which are considered to reflect stomach atrophy, a high‐risk condition for stomach cancer.

Keywords: Tea polyphenols, Pepsinogens, Adverse effects, Phase II trial

Full Text

The Full Text of this article is available as a PDF (86.5 KB).

REFERENCES

  • 1. ) Tajima , K. and Tominaga , S.Dietary habits and gastrointestinal cancer: a comparative case‐control study of stomach and large intestinal cancers in Nagoya, Japan . Jpn. J. Cancer Res. , 76 , 705 – 716 ( 1985. ). [PubMed] [Google Scholar]
  • 2. ) Kono , S. , Ikeda , M. , Tokudome , S. and Kuratsune , M.A case‐control stuy of gastric cancer and diet in Northern Kyushu, Japan . Jpn. J. Cancer Res. , 79 , 1067 – 1074 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. ) Inoue , M. , Tajima , K. , Hirose , K. , Hamajima , N. , Takezaki , T. , Kuroishi , T. and Tominaga , S.Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case‐referent study in Japan . Cancer Causes Control , 9 , 209 – 216 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Yu , G.‐P. , Hsieh , C.‐C. , Wang , L.‐Y. , Yu , S.‐Z. , Li , X.‐L. and Jin , T.‐H.Green‐tea consumption and risk of stomach cancer: a population‐based case‐control study in Shanghai, China . Cancer Causes Control , 6 , 532 – 538 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Ji , B.‐T. , Chow , W.‐H. , Yang , G. , McLaughlin , J. K. , Gao , R.‐N. , Zheng , W. , Shu , X.‐O. , Jin , F. , Fraumeni , J. F. , Jr. and Gao , Y.‐T.The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China . Cancer , 77 , 2449 – 2457 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Yang , C. S. and Wang , Z.‐Y.Tea and cancer . J. Natl. Cancer Inst. , 85 , 1038 – 1049 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Weisburger , J. H. , Hara , Y. , Dolan , L. , Luo , F. Q. , Pittman , B. and Zang , E.Tea polyphenols as inhibitors of Mutagenicity of major classes of carcinogens . Mutat. Res. , 371 , 57 – 63 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Jankun , J. , Selman , S. H. and Swiercz , R.Why drinking green tea could prevent cancer . Nature , 387 , 561 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Yoshizawa , S. , Horiuchi , T. , Fujiki , H. , Yoshida , T. , Okuda , T. and Sugimura , T.Antitumor promoting activity of (‐)‐epigallocatechin gallate, the main constituent of “tannin” in green tea . Phytother. Res. , 1 , 44 – 47 ( 1987. ). [Google Scholar]
  • 10. ) Ahmad , N. , Feyes , D. K. , Nieminen , A.‐L. , Agarwal , R. and Mukhtar , H.Green tea constituent epigallocatechin‐3‐gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells . J. Natl. Cancer Inst. , 89 , 1881 – 1886 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Yang , G.‐Y. , Liao , J. , Kim , K. , Yurkow , E. J. and Yang , C. S.Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols . Carcinogenesis , 19 , 611 – 616 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Kato , I. , Tominaga , S. , Ito , Y. , Kobayashi , S. , Yoshii , Y. , Matsuura , A. , Kameya , A. , Kano , T. and Ikari , A.A prospective study of atrophic gastritis and stomach cancer risk . Jpn. J. Cancer Res. , 83 , 1137 – 1142 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. ) Dixon , M. F.Helicobacter pylori and peptic ulceration: histopathological aspects . J. Gastroenterol. Hepatol. , 6 , 125 – 130 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Fukao , A. , Komatsu , S. , Tsubono , Y. , Hisamichi , S. , Ohori , H. , Kizawa , T. , Ohsato , N. , Fujino , N. , Endo , N. and Iha , M.Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross‐sectional study . Cancer Causes Control , 4 , 307 – 312 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Kuipers , E. J. , Uyterlinde , A. M. , Pena , A. S. , Roosendaal , R. , Pals , G. , Nelis , G. F. , Festen , H. P. M. and Meuwissen , S. G. M.Long‐term sequelae of Helicobacter pylori gastritis . Lancet , 345 , 1525 – 1528 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Nomura , A. , Stemmermann , G. N. , Chyou , P.‐H. , Kato , I. , Perez‐Perez , G. I. and Blaser , M. J.Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii . N. Engl. J. Med. , 325 , 1132 – 1136 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Asaka , M. , Kimura , T. , Kato , M. , Kudo , M. , Miki , K. , Ogoshi , K. , Kato , T. , Tatsuta , M. and Graham , D. Y.Possible role of Helicobacter pylori infection in early gastric cancer development . Cancer , 73 , 2691 – 2694 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Kikuchi , S. , Wada , O. , Nakajima , T. , Nishi , T. , Kobayashi , O. , Konishi , T. , Inaba , Y.and the Research Group on Prevention of Gastric Carcinoma among Young Adults. Serum anti‐Helicobacter pylori antibody and gastric carcinoma among young adults . Cancer , 75 , 2789 – 2793 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Fukuda , H. , Saito , D. , Hayashi , S. , Hisai , H. , Ono , H. , Yoshida , S. , Oguro , Y. , Noda , T. , Sato , T. , Katoh , M. , Terada , M. and Sugimura , T.Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a casecontrol study in Japan . Jpn. J. Cancer Res. , 86 , 64 – 71 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Inoue , M. , Kobayashi , S. , Matsuura , A. , Hamajima , N. , Tajima , K. and Tominaga , S.Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis . Cancer Epidemiol. Biomarker Prev. , 7 , 261 – 263 ( 1998. ). [PubMed] [Google Scholar]
  • 21. ) SAS Institute Inc. “SAS/STAT User/rquote s Guide, Version 6” ( 1990. ). SAS Institute Inc. , Cary , NC . [Google Scholar]
  • 22. ) Blot , W. J. , Li , J.‐Y. , Taylor , P. R. , Guo , W. , Dawsey , S. , Wang , G.‐Q. , Yang , C. S. , Zheng , S.‐F. , Gail , M. , Li , G.‐Y. , Yu , Y. , Liu , B.‐Q. , Tangrea , J. , Sun , Y.‐H. , Liu , F. , Fraumeni , J. F.Jr. , Zhang , Y.‐H. and Li , B.Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease‐specific mortality in the general population . J. Natl. Cancer Inst. , 85 , 1483 – 1492 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Varis , K. , Taylor , P. R. , Sipponen , P. , Samloff , I. M. , Heinonen , O. P. , Albanes , D. , Harkonen , M. , Huttunen , J. K. , Laxen , F. , Virtamo , J.and the Helsinki Gastritis Study Group. Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha‐tocopherol and beta‐carotene. Scand. J. Gastroenterol. , 33 , 294 – 300 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Munoz , N. , Vivas , J. , Buiatti , I. , Kato , I. and Oliver , W.Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data . IARC Sci. Publ. , 139 , 125 – 133 ( 1996. ). [PubMed] [Google Scholar]
  • 25. ) Buiatti , E. and Munoz , N.Chemoprevention of stomach cancer . IARC Sci. Publ. , 136 , 35 – 39 ( 1996. ). [PubMed] [Google Scholar]
  • 26. ) Reed , P. I. and Johnston , B. J.Primary prevention of gastric precancerous lesions . Eur. J. Cancer Prev. , 2 ( Suppl. 2 ), 79 – 82 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Tsubono , Y. , Okubo , S. , Hayashi , M. , Kakizoe , T. and Tsugane , S.A randomized controlled trial for chemoprevention of gastric cancer in high‐risk Japanese population; study design, feasibility and protocol modification . Jpn. J. Cancer Res. , 88 , 344 – 349 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. ) Shirai , T. , Sato , A. , Chida , K. , Hayakawa , H. , Akiyama , J. , Iwata , M. , Taniguchi , M. , Reshad , K. and Hara , Y.Epigallocatechin gallate‐induced histamine release in patients with green tea‐induced asthma . Ann. Allergy Asthma Immunol. , 79 , 65 – 69 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Goto , K. , Kanaya , S. , Nishikawa , T. , Hara , H. , Terada , A. , Ishigami , T. and Hara , Y.The influence of tea catechins on fecal flora of elderly residents in long‐term care facilities . Ann. Long-Term Care , 6 , 43 – 48 ( 1998. ). [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES